Skip to content

Clinical trials

Phase 2 Uterine Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Neoplasms Phase: Phase 2 Country / region: United States Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20032
20043
20051
20067
20081
20101
20112
20122
20152
20161
20173
20182
20192
20202
20211
20232
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated10
Recruiting7
Active, not recruiting3
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center6
Dana-Farber Cancer Institute3
Eli Lilly and Company3
Montefiore Medical Center3
Abramson Cancer Center at Penn Medicine2
Novartis Pharmaceuticals2
University of Alabama at Birmingham2
Bay Area Gynecology Oncology1
Denise Fabian1
Elevation Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Neoplasms44
Ovarian Neoplasms16
Endometrial Neoplasms14
Uterine Cervical Neoplasms12
Breast Neoplasms7
Fallopian Tube Neoplasms5
Neoplasms5
Colorectal Neoplasms4
Urinary Bladder Neoplasms4
Vulvar Neoplasms4

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.